Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


15.01.2018

2 Acta Neurol Scand
2 Diabet Med
12 Diabetes
2 Diabetes Res Clin Pract
4 J Autoimmun
3 J Immunol
4 J Neuroimmunol
1 Kidney Int
13 Mult Scler
1 N Engl J Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. CAMBRON M, Hadhoum N, Duhin E, Lacour A, et al
    JCV serology in time: 3 years of follow-up.
    Acta Neurol Scand. 2017;136:54-58.
    PubMed     Text format     Abstract available

  2. MESCHERIAKOVA JY, Hintzen RQ
    No excess of autoimmune diseases in multiple sclerosis families from the Netherlands.
    Acta Neurol Scand. 2018 Jan 7. doi: 10.1111/ane.12896.
    PubMed     Text format     Abstract available


    Diabet Med

  3. SCANLON PH, Stratton IM, Bachmann MO, Jones C, et al
    Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.
    Diabet Med. 2016 Sep 20. doi: 10.1111/dme.13263.
    PubMed     Text format     Abstract available

  4. RUDDOCK JS, Poindexter M, Gary-Webb TL, Walker EA, et al
    Innovative strategies to improve diabetes outcomes in disadvantaged populations.
    Diabet Med. 2016;33:723-33.
    PubMed     Text format     Abstract available


    Diabetes

  5. DREXHAGE HA, Dik WA, Leenen PJ, Versnel MA, et al
    The Immune Pathogenesis of Type 1 Diabetes: Not Only Thinking Outside the Cell but Also Outside the Islet and Out of the Box.
    Diabetes. 2016;65:2130-3.
    PubMed     Text format    

  6. NEL I, Lehuen A
    Defective Invariant Natural Killer T-Cell Suppression in Patients With Type 1 Diabetes.
    Diabetes. 2016;65:2121-3.
    PubMed     Text format    

  7. BELGARDT BF, Lammert E
    DYRK1A: A Promising Drug Target for Islet Transplant-Based Diabetes Therapies.
    Diabetes. 2016;65:1496-8.
    PubMed     Text format    

  8. GLISIC S, Ghosh S
    Comment on Yang et al. Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes. Diabetes 2015;64:3891-3902.
    Diabetes. 2016;65:e21.
    PubMed     Text format    

  9. LI J, Huynh P, Dai A, Wu T, et al
    Diabetes Reduces Severity of Aortic Aneurysms Depending on the Presence of Cell Division Autoantigen 1 (CDA1).
    Diabetes. 2018 Jan 8. pii: db17-0134. doi: 10.2337/db17-0134.
    PubMed     Text format     Abstract available

  10. RETNAKARAN R
    The Insulin-Like Growth Factor Axis: A New Player in Gestational Diabetes Mellitus?
    Diabetes. 2016;65:3246-3248.
    PubMed     Text format    

  11. HEUTS F, Edner NM, Walker LS
    Follicular T Helper Cells: A New Marker of Type 1 Diabetes Risk?
    Diabetes. 2017;66:258-260.
    PubMed     Text format    

  12. FAN Y
    Bait and Trap: Enriching Autoreactive T Cells With beta-Cell Antigen-Loading Biomaterial Scaffolds for Early Detection of Type 1 Diabetes.
    Diabetes. 2017;66:2066-2068.
    PubMed     Text format    

  13. SUI L, Danzl N, Campbell SR, Viola R, et al
    Beta Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells.
    Diabetes. 2017 Sep 20. pii: db170120. doi: 10.2337/db17-0120.
    PubMed     Text format     Abstract available

  14. MILLER WP, Yang C, Mihailescu ML, Moore JA, et al
    Deletion of the Akt/mTORC1 Repressor REDD1 Prevents Visual Dysfunction in a Rodent Model of Type 1 Diabetes.
    Diabetes. 2017 Oct 26. pii: db170728. doi: 10.2337/db17-0728.
    PubMed     Text format     Abstract available

  15. ZHOU C, Routh VH
    Thioredoxin-1 Overexpression in the Ventromedial Nucleus of the Hypothalamus (VMH) Preserves the Counterregulatory Response to Hypoglycemia During Type 1 Diabetes Mellitus in Male Rats.
    Diabetes. 2017 Oct 27. pii: db170930. doi: 10.2337/db17-0930.
    PubMed     Text format     Abstract available

  16. MANDRUP-POULSEN T
    Granzyme A in the Pathogenesis of Type 1 Diabetes: The Yes and the No.
    Diabetes. 2017;66:2937-2939.
    PubMed     Text format    


    Diabetes Res Clin Pract

  17. KHUNTI K, Alsifri S, Aronson R, Cigrovski Berkovic M, et al
    Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
    Diabetes Res Clin Pract. 2017;130:121-129.
    PubMed     Text format     Abstract available

  18. THAKKAR UG, Vanikar AV, Trivedi HL
    Stem cells: An emerging novel therapeutic for type-1 diabetes mellitus.
    Diabetes Res Clin Pract. 2017;130:130-132.
    PubMed     Text format     Abstract available


    J Autoimmun

  19. SHARMA A, Liu X, Hadley D, Hagopian W, et al
    Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
    J Autoimmun. 2018 Jan 5. pii: S0896-8411(17)30739.
    PubMed     Text format     Abstract available

  20. EVANGELISTA F, Roth AJ, Prisayanh P, Temple BR, et al
    Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.
    J Autoimmun. 2018 Jan 4. pii: S0896-8411(17)30766.
    PubMed     Text format     Abstract available

  21. JAMIN A, Berthelot L, Couderc A, Chemouny JM, et al
    Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice.
    J Autoimmun. 2018 Jan 4. pii: S0896-8411(17)30684.
    PubMed     Text format     Abstract available

  22. YAO Y, Li L, Yang SH, Gao CY, et al
    CD8(+) T cells and IFN-gamma induce autoimmune myelofibrosis in mice.
    J Autoimmun. 2018 Jan 4. pii: S0896-8411(17)30763.
    PubMed     Text format     Abstract available


    J Immunol

  23. JEONG HJ, Lee HJ, Ko JH, Cho BJ, et al
    Myeloid-Derived Suppressor Cells Mediate Inflammation Resolution in Humans and Mice with Autoimmune Uveoretinitis.
    J Immunol. 2018 Jan 8. pii: jimmunol.1700617. doi: 10.4049/jimmunol.1700617.
    PubMed     Text format     Abstract available

  24. BURRACK AL, Landry LG, Siebert J, Coulombe M, et al
    Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.
    J Immunol. 2018 Jan 8. pii: jimmunol.1700856. doi: 10.4049/jimmunol.1700856.
    PubMed     Text format     Abstract available


  25. Correction: NFAT1 Regulates Systemic Autoimmunity through the Modulation of a Dendritic Cell Property.
    J Immunol. 2018;200:880.
    PubMed     Text format    


    J Neuroimmunol

  26. DETRICK B, Gangaputra S, Palsgrove DN, Heaney CD, et al
    Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients.
    J Neuroimmunol. 2017 Dec 29. pii: S0165-5728(17)30269.
    PubMed     Text format     Abstract available

  27. ROZMILOWSKA IM, Adamczyk-Sowa MH
    What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?
    J Neuroimmunol. 2018;315:50-57.
    PubMed     Text format    

  28. KUHN I, Rogosch T, Schindler TI, Tackenberg B, et al
    Serum titers of autoantibodies against alpha-synuclein and tau in child- and adulthood.
    J Neuroimmunol. 2018;315:33-39.
    PubMed     Text format     Abstract available

  29. GEORGE JD, Kim E, Spain R, Bourdette D, et al
    Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis.
    J Neuroimmunol. 2018;315:24-27.
    PubMed     Text format     Abstract available


    Kidney Int

  30. BOMBACK AS, Santoriello D, Avasare RS, Regunathan-Shenk R, et al
    C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Kidney Int. 2018 Jan 6. pii: S0085-2538(17)30802.
    PubMed     Text format     Abstract available


    Mult Scler

  31. HAASE S, Haghikia A, Gold R, Linker RA, et al
    Dietary fatty acids and susceptibility to multiple sclerosis.
    Mult Scler. 2018;24:12-16.
    PubMed     Text format     Abstract available

  32. HARROUD A, Richards JB
    Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity?
    Mult Scler. 2018;24:80-85.
    PubMed     Text format     Abstract available

  33. DOLEI A
    The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis.
    Mult Scler. 2018;24:42-47.
    PubMed     Text format     Abstract available

  34. CANTO E, Oksenberg JR
    Multiple sclerosis genetics.
    Mult Scler. 2018;24:75-79.
    PubMed     Text format     Abstract available

  35. WAUBANT E
    Effect of puberty on multiple sclerosis risk and course.
    Mult Scler. 2018;24:32-35.
    PubMed     Text format     Abstract available

  36. VOSKUHL RR, Sawalha AH, Itoh Y
    Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression.
    Mult Scler. 2018;24:22-31.
    PubMed     Text format     Abstract available

  37. TANKOU SK, Regev K, Healy BC, Cox LM, et al
    Investigation of probiotics in multiple sclerosis.
    Mult Scler. 2018;24:58-63.
    PubMed     Text format     Abstract available

  38. CASTRO K, Casaccia P
    Epigenetic modifications in brain and immune cells of multiple sclerosis patients.
    Mult Scler. 2018;24:69-74.
    PubMed     Text format     Abstract available

  39. DAMOTTE V, Lizee A, Tremblay M, Agrawal A, et al
    Harnessing electronic medical records to advance research on multiple sclerosis.
    Mult Scler. 2018 Jan 1:1352458517747407. doi: 10.1177/1352458517747407.
    PubMed     Text format     Abstract available

  40. DE STEFANO N, Giorgio A
    Response to 'Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?' by Schiffmann et al.
    Mult Scler. 2018 Jan 1:1352458517748476. doi: 10.1177/1352458517748476.
    PubMed     Text format    

  41. SCHIFFMANN I, Scheiderbauer J, Riemann-Lorenz K, Heesen C, et al
    Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?
    Mult Scler. 2018 Jan 1:1352458517749895. doi: 10.1177/1352458517749895.
    PubMed     Text format    

  42. SEGAL BM, Cohen JA, Antel J
    Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2017: Environmental factors, genetics, and epigenetics in MS susceptibility and clinical course.
    Mult Scler. 2018;24:4-5.
    PubMed     Text format     Abstract available

  43. TREMLETT H, Waubant E
    Gut microbiome and pediatric multiple sclerosis.
    Mult Scler. 2018;24:64-68.
    PubMed     Text format     Abstract available


    N Engl J Med

  44. REICH DS, Lucchinetti CF, Calabresi PA
    Multiple Sclerosis.
    N Engl J Med. 2018;378:169-180.
    PubMed     Text format    


    PLoS One

  45. GREENFIELD J, Hudson M, Vinet E, Fortin PR, et al
    A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs).
    PLoS One. 2017;12:e0189840.
    PubMed     Text format     Abstract available

  46. CHEN Y, Zhen W, Guo T, Zhao Y, et al
    Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
    PLoS One. 2017;12:e0189380.
    PubMed     Text format     Abstract available

  47. SASIDHAR MV, Chevooru SK, Eickelberg O, Hartung HP, et al
    Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    PLoS One. 2017;12:e0189701.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: